FDA recommends strategies to conserve prefilled saline flush syringes

The Food and Drug Administration today recommended strategies for health care providers to conserve prefilled 0.9% sodium chloride intravenous lock/flush syringes, which are in short supply due to increased demand during the COVID-19 public health emergency and recent vendor supply chain challenges. The agency said it is working with manufacturers to help mitigate the shortage.
Related News Articles
Headline
The House Energy and Commerce Committee held a hearing on legislative proposals to prevent and respond to generic drug shortages. In comments submitted…
Headline
AHA recently voiced support for four bipartisan bills introduced in the Senate to help alleviate the nation’s chronic and growing drug shortages.
…
News
Pfizer will ship certain sterile injectable products directly to customers under an emergency ordering process implemented yesterday due to high demand for the…
Headline
The Food and Drug Administration said it did not expect “any immediate significant impacts on supply” after a tornado damaged a Pfizer plant in North…
Headline
The Senate Health, Education, Labor and Pensions Committee today 17-3 to pass as amended the Pandemic and All-Hazards Preparedness and Response Act (S. 2333),…
Headline
AHA is weighing in on drug shortages that impact patient care in response to a request by Republican leaders in the House and Senate. Rep. Cathy McMorris…